Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methotrexate Early Toxicity Monitoring in Primary Central Nervous System Lymphomas (PCNSL)

NCT07406230 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT07406230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07406230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methotrexate Early Toxicity Monitoring in Primary Central Nervous System Lymphomas (PCNSL)
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary central nervous system lymphoma